| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a43c3a83bacec45ece61276d9c8b27e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa2386d5541066d5f0b8c41ede3f02e9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate |
2018-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ec6b38fa25aa66d552dcaf5db696d4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_130cf702d1cf102f68bb5f656d24b4bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29c9ed5d74344d56d5fcabf5e067653d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6da206b81399b1fe1619e203524b8085 |
| publicationDate |
2021-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3787670-A1 |
| titleOfInvention |
Induction of allergen-specific tregs prior to oral or sublingual immunotherapy of food allergy |
| abstract |
The present invention relates to methods for the induction of food tolerance by a combination of subcutaneous hydrogel immunotherapy with T-cell peptides derived from food allergens in the presence of oligodeoxynucleotide tolerant concentrations. with CpG or GpC or GpG (Phase A) motifs followed by oral or sublingual immunotherapy with natural or recombinant food allergens (Phase B). |
| priorityDate |
2017-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |